WNS to acquire Value Edge Research for USD 17.5 million

WNS Holdings Ltd, a top Business Process Management (BPM) services company, has entered into an agreement to buy commercial research and analytics services firm Value Edge Research Services for USD 17.5 million.
"We have entered into a definitive agreement to acquire Value Edge Research Services, a leading provider of commercial research and analytics services to clients in the pharma/biopharma industry," WNS said in a statement here.
The acquisition is subject to Reserve Bank of India (RBI) approval and other customary closing conditions, and is expected to close in the first quarter of fiscal 2017, the NYSE-listed firm said.
Value Edge employs over 100 people in India, the US and Europe. It provides consulting grade marketing and data analytics to a blue-chip roster of globally leading bio-pharma companies.

The firm has created a cloud-based advanced technology platform designed to provide clients with competitive intelligence (CI) to drive strategic decision-making.
It also provides services in the areas of pricing analytics, patient data analysis, key account management, sales force effectiveness and social media monitoring.

"The acquisition of Value Edge deepens our domain and specialised analytical capabilities in the growing pharma market, and provides WNS with a technology asset which is leverageable across clients and industries," WNS' Chief Executive Officer Keshav Murugesh said.
"Value Edge is excited to partner with WNS, and the combination of our firm's respective capabilities will enable us to help clients in the pharma/ bio-pharma industry improve their competitive positioning," Value Edge MD Rohit Anand said.

"We believe WNS' global size and strength will allow us to tap new areas of demand, drive deeper relationships and expand our offerings," Anand said.